NCT05236049View on ClinicalTrials.gov

Use of an Allograft Set-up (SclerFIX) as Replacement of Sclera Graft for Support of Enucleation Implant

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

April 27, 2022

Study Completion Date

April 27, 2022

Conditions

Enucleated; EyeEye Cancer

Interventions

BIOLOGICAL

SclerFIX

Chemically-treated, viro-inactivated, freeze-dried and irradiated umbilical cord lining membrane allograft used as substitute for scleral graft in support of intraocular implant.

Trial Locations (1)

75005

Institut Curie, Paris